Intrinsic value of Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Live fair value data for Telomir Pharmaceuticals, Inc. Common Stock (TELO) is currently unavailable. Please check again shortly.
Current Price: $408.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Telomir Pharmaceuticals, Inc. Common Stock (TELO) undervalued or overvalued?
Based on the current model output, Telomir Pharmaceuticals, Inc. Common Stock appears to be overvalued with a downside of 9.00%.
Fair value vs market price — Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Unlock premium access to view the live fair value comparison against current market price for TELO.
Frequently Asked Questions - TELO
How is TELO intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TELO.
Is TELO undervalued or overvalued right now?
TELO is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TELO: open their intrinsic value pages.